Target intelligence / Profile preview

Sulfotransferase family 1A member 3 (SULT1A3)

Target
SULT1A3
Molecular classification
Enzyme, Cytosolic sulfotransferase, Phase II drug-metabolizing enzyme
01

Overview

Sulfotransferase family 1A member 3 (SULT1A3) is a cytosolic enzyme that catalyzes the sulfate conjugation of phenolic monoamines using PAPS as the sulfonate donor, primarily targeting neurotransmitters like dopamine, norepinephrine, serotonin, and related catechol or phenolic compounds. This enzyme plays an essential role in the detoxification and presystemic elimination of dietary and endogenous catecholamines, both in the gastrointestinal tract and the brain, protecting against catecholamine-induced neurotoxicity. SULT1A3 is highly expressed in primates’ intestine, brain, platelets, lung, and kidney. Since its expression and catalytic activity vary among individuals and tissue types, it has implications for drug metabolism, interindividual variability in pharmacological responses, and potential links to neurological and metabolic disorders.

Other names
Sulfotransferase 1A3STMST1A3TL-PSTAryl sulfotransferase 1A3/1A4Catecholamine-sulfating phenol sulfotransferaseHAST3M-PSTMonoamine-sulfating phenol sulfotransferasePlacental estrogen sulfotransferaseSulfotransferase 1A3/1A4Sulfotransferase, monoamine-preferringThermolabile phenol sulfotransferaseHASTST1A3/ST1A4ST1A4ST1A5aryl sulfotransferase 1A3/1A4dopamine-specific sulfotransferasephenol sulfotransferase 1A5sulfokinasecytosolic phenol-preferring sulfotransferase, M-form
02

Mechanism of action

Drugs and endogenous substances are metabolized by sulfate conjugation using PAPS (3'-phospho-5'-adenylyl sulfate) as the sulfonate donor, thereby increasing water solubility and facilitating excretion Inactivation and detoxification of neurotransmitters by sulfation (dopamine sulfate formation)

03

Biological functions

Sulfation of catecholamines (e.g., dopamine, serotonin, norepinephrine, epinephrine)Biotransformation and detoxification of hormones, neurotransmitters, and xenobioticsMetabolism of phenolic and catechol drugsNeuroprotection against catecholamine toxicityPresystemic elimination of dietary and circulating dopamine
04

Disease associations

Neurodegenerative disease (dopamine neurotoxicity and its modulation)Dengue shock syndrome (association)Churg-Strauss syndrome (association)Potentially implicated in other diseases involving neurotransmitter imbalance
05

Safety considerations

Polymorphisms and variable expression patterns may affect drug metabolism and neurotransmitter regulation, potentially leading to altered CNS drug response, neurotoxicity, or adverse drug reactionsNon-human model limitations: SULT1A3 is primate-specific, not present in rodents, complicating preclinical translatability
06

Interacting drugs

Formononetin

2 more in the full profile.

07

Biomarkers

SULT1A3 expression/activity may serve as a biomarker for individual capacity to clear catecholamines and certain drugs in intestine, liver, or brainNot established as a clinical biomarker for patient selection at this time

Beyond the preview

Go deeper on Sulfotransferase family 1A member 3 (SULT1A3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sulfotransferase family 1A member 3 (SULT1A3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call